metyrapone has been researched along with Delirium of Mixed Origin in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, T | 1 |
| Oda, M | 1 |
| Kuno, T | 1 |
| Ueki, H | 1 |
| Yamada, S | 1 |
| Hisatomi, A | 1 |
| Kramlinger, KG | 1 |
| Peterson, GC | 1 |
| Watson, PK | 1 |
| Leonard, LL | 1 |
2 other studies available for metyrapone and Delirium of Mixed Origin
| Article | Year |
|---|---|
Metyrapone for delirium due to Cushing's syndrome induced by occult ectopic adrenocorticotropic hormone secretion.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Cushing Syndrome; Delirium; Enzyme Inhibitors; | 2004 |
Metyrapone for depression and delirium secondary to Cushing's syndrome.
Topics: Cushing Syndrome; Delirium; Depressive Disorder; Humans; Male; Metyrapone; Middle Aged | 1985 |